Cécile de Chaisemartin

Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6)

Jérémie H. Lefèvre, Laurent Mineur, Salma Kotti et al. · Journal of Clinical Oncology · 2016 · 462 citations

Rectal Tumor, Surgical Oncology, Health Sciences +15

Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial

Éric Rullier, V. Vendrely, Julien Asselineau et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 238 citations

Surgical Oncology, Radiation Therapy, Greccar 2 +8

A Step Toward NOTES Total Mesorectal Excision for Rectal Cancer

Jean–Jacques Tuech, Mehdi Karoui, Bernard Lelong et al. · Annals of Surgery · 2014 · 184 citations

Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers

Mehdi Karoui, Anne Rullier, Guillaume Piessen et al. · Annals of Surgery · 2019 · 126 citations

A multicentre randomised controlled trial to evaluate the efficacy, morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAP-GRECCAR 11 TRIAL): rationale and design

Bernard Lelong, Cécile de Chaisemartin, Hélène Meillat et al. · BMC Cancer · 2017 · 116 citations · Full text